WebJun 22, 2024 · Bijan Almassian, PhD President & CEO [email protected] +1-203-815-5782. Amy Lamperti VP, Commercialization [email protected] +1-201-572-1554. Get updates. Email * CAPTCHA. Phone. This field is for validation purposes and should be left unchanged. Recent Posts. WebJul 6, 2012 · Patents by Inventor Bijan Almassian. Bijan Almassian has filed for patents to protect the following inventions. This listing includes patent applications that are pending …
CaroGen and Wayne State University scientists report significant ...
WebVery honored to be selected by Hartford Business Journal as one of top 25 technology companies in state of Connecticut. We develop breakthrough immunotherapies and … Web16 hours ago · In "dictatorial" Syria, Muslims, Christians, and Jews practice their religious rituals freely. No one beats them up. 15 Apr 2024 15:49:48 tedan atp
Bijan ALMASSIAN CEO Research profile
WebBijan Almassian; Martin Joseph Sadowski; Xu Kevin Lin; Compounds are provided according to formula I: where R, R′, R3, R4, R5, and R6 are as defined herein. Provided compounds and pharmaceutical ... WebBijan Almassian is the President & CEO at CaroGen. CaroGen President & CEO Jul 2012. Related Hubs. Edit Related Hubs Section. Hub Name . CB Rank (Hub) Pharmaceutical … WebCaroGen Corporation was founded by Drs. Bijan Almassian, Valerian Nakaar, Michael Robek, and John Rose to develop and commercialize novel immunotherapy approaches using the virus-like vesicle (VLV) platform. This patented platform was invented by Professor John Rose at Yale University School of Medicine and exclusively licensed to CaroGen. tedandmems